Download PDF
Thromb Haemost 1997; 78(01): 386-391
DOI: 10.1055/s-0038-1657557
Thrombomodulin
Schattauer GmbH Stuttgart

Thrombin, Thrombomodulin and TAFI in the Molecular Link Between Coagulation and Fibrinolysis

Michael Nesheim
Queen’s University, Kingston, Ontario, Canada; and Berlex Biosciences, Richmond, CA, USA
,
Wei Wang
Queen’s University, Kingston, Ontario, Canada; and Berlex Biosciences, Richmond, CA, USA
,
Michael Boffa
Queen’s University, Kingston, Ontario, Canada; and Berlex Biosciences, Richmond, CA, USA
,
Mariko Nagashima
Queen’s University, Kingston, Ontario, Canada; and Berlex Biosciences, Richmond, CA, USA
,
John Morser
Queen’s University, Kingston, Ontario, Canada; and Berlex Biosciences, Richmond, CA, USA
,
Laszlo Bajzar
Queen’s University, Kingston, Ontario, Canada; and Berlex Biosciences, Richmond, CA, USA
› Author Affiliations
Further Information

Publication History

Publication Date:
12 July 2018 (online)

Also available at
  PDF Download  Permissions and Reprints
 

  • References

  • 1 Stenflo JA. New vitamin K-dependent protein Purification from bovine plasma and preliminary characterization. J Biol Chem 251 1976; 355-363
    PubMedGoogle Scholar
  • 2 Kisiel W. Human Plasma Protein C Isolation, Characterization, and Mechanism of Activation by Alpha-Thrombin. J Clin Invest 1979; 64: 761-769
    CrossrefPubMedGoogle Scholar
  • 3 Kisiel W, Ericsson LH, Davie EW. Proteolytic activation of protein C from bovine plasma. Biochemistry 15 1976; 4893-4900
    CrossrefPubMedGoogle Scholar
  • 4 Nesheim ME, Canfield WM, Kisiel W, Mann KG. Modulation of prothrombinase activity through inactivation of factor Va by protein Ca. Blood 1979; 54: 293
    PubMedGoogle Scholar
  • 5 Walker FJ, Sexton PW, Esmon CT. The inhibition of blood coagulation by activated protein C through the selective inactivation of activated factor V. Biochim Biophys Acta 1979; 71: 333-342
    PubMedGoogle Scholar
  • 6 Vehar GA, Davie EW. Preparation and properties of bovine factor VIII. Biochemistry 1980; 19: 401-409
    CrossrefPubMedGoogle Scholar
  • 7 Esmon CT, Owen WG. Identification of an endothelial cell cofactor for thrombin-catalyzed activation of protein C. Proc Natl Acad Sci USA 1981; 78: 2249-2252
    CrossrefPubMedGoogle Scholar
  • 8 Owen WG, Esmon CT. Functional properties of an endothelial cell cofactor for thrombin catalyzed activation of protein C. J Biol Chem 256 1981; 5532-5535
    PubMedGoogle Scholar
  • 9 Esmon NL, Owen WG, Esmon CT. Isolation of a membranebound cofactor for thrombin-catalyzed activation of protein C. J Biol Chem 257 1982; 859-864
    PubMedGoogle Scholar
  • 10 Jackman RW, Beeler DL, Van De Water L, Rosenberg RD. Characterization of a thrombomodulin cDNA reveals structural similarity to the low density lipoprotein receptor. Proc Natl Acad Sci USA 83 1986; 8834-8838
    CrossrefPubMedGoogle Scholar
  • 11 Wen D, Dittman WA, Ye RD, Deaven LL, Majerus PW, Sadler JE. Human thrombomodulin: complete cDNA sequence and chromosome localization of the gene. Biochemistry 1987; 26: 4350-4357
    CrossrefPubMedGoogle Scholar
  • 12 Suzuki K, Kusumoto H, Deyashiki Y, Nishioka J, Maruyama I, Zushi M, Kawahara S, Honda G, Yamamoto S, Horiguchi S. Structure and expression of human thrombomodulin, a thrombin receptor on endothelium acting as a cofactor for protein C activation. EMBO J 06 1987; 1891-1897
    PubMedGoogle Scholar
  • 13 Jackman RW, Beeler DL, Fritze L, Soff G, Rosenberg RD. Human thrombomodulin gene is intron depleted: Nucleic acid sequences of the cDNA and gene predict protein structure and suggest sites of regulatory control. Proc Natl Acad Sci USA 84 1987; 6425-6429
    CrossrefPubMedGoogle Scholar
  • 14 Sadler JE, Lentz SR, Sheehan JP, Tsiang M, Wu Q. Structure-function relationships of the thrombin-thrombomodulin interaction. Haemost 23 1993; 183-193
    CrossrefPubMedGoogle Scholar
  • 15 Esmon CT. Thrombomodulin as a model of molecular mechanisms that modulate protease specificity and function at the vessel surface. FASEB J 09 1995; 946-955
    CrossrefPubMedGoogle Scholar
  • 16 Esmon CT. Molecular events that control the protein C anticoagulant pathway. Thromb Haemost 70 1993; 29-35
    PubMedGoogle Scholar
  • 17 Healy AM, Rayburn HB, Rosenberg RD, Weiler H. Absence of the blood clotting regulator thrombomodulin causes embryonic lethality in mice before development of a functional cardiovascular system. Proc Natl Acad Sci USA 92 1995; 850-854
    CrossrefPubMedGoogle Scholar
  • 18 Bajzar L, Manuel R, Nesheim ME. Purification and characterization of TAFI, a thrombin activatable fibrinolysis inhibitor. J Biol Chem 1995; 270: 14477-14484
    CrossrefPubMedGoogle Scholar
  • 19 Bajzar L, Morser J, Nesheim M. TAFI, or plasma procarboxypeptidase B, couples the coagulation and fibrinolytic cascades through the thrombin-thrombomodulin complex. J Biol Chem 271 1996; 16603-16608
    CrossrefPubMedGoogle Scholar
  • 20 Eaton DL, Malloy BE, Tsai SP, Henzel W, Drayna D. Isolation, molecular cloning, and partial characterization of a novel carboxypeptidase B from human plasma. J Biol Chem 1991; 269: 21833-21838
    PubMedGoogle Scholar
  • 21 Tan AK, Eaton DL. Activation and characterization of procarboxypeptidase B from human plasma. Biochemistry 1995; 34: 5811-5816
    CrossrefPubMedGoogle Scholar
  • 22 Taylor FB, Carroll RC, Gerrard J, Esmon CT, Radcliffe RD. Lysis of clots prepared from whole blood and plasma. FASEB J 40 1981; 2092-2098
    PubMedGoogle Scholar
  • 23 Comp PC, Esmon CT. Generation of fibrinolytic activity by infusion of activated protein C into dogs. J Clin Invest 1981; 68: 1221-1228
    CrossrefPubMedGoogle Scholar
  • 24 Taylor FB, Lockhart MS. A new function for activated protein C: activated protein C prevents inhibition of plasminogen activators by releasate from mononuclear leukocytes — platelet suspensions stimulated by phorbol diester. Thromb Res 37 1985; 155-164
    CrossrefPubMedGoogle Scholar
  • 25 Sakata Y, Loskutoff DJ, Gladson CL, Hekman CM, Griffin JH. Mechanism of protein C-dependent clot lysis: role of plasminogen activator inhibitor. Blood 68 1986; 1218-1223
    CrossrefPubMedGoogle Scholar
  • 26 de Fouw NJ, Haverkate F, Bertina RM, Koopman J, van Wijngaarden A, van Hinsbergh VWM. The cofactor role of protein S in the acceleration of whole blood clot lysis by activated protein C in vitro. Blood 67 1986; 1189-1192
    PubMedGoogle Scholar
  • 27 Burdick MD, Schaub RG. Human protein C induces anticoagulation and increased fibrinolytic activity in the cat. Thromb Res 45 1987; 413-419
    CrossrefPubMedGoogle Scholar
  • 28 de Fouw NJ, Bertina RM, Haverkate F. Stimulation of fibrinolysis by activated protein C (APC). Thromb Haemost 1987; 58: 48
    PubMedGoogle Scholar
  • 29 de Fouw NJ, de Jong YF, Haverkate F, Bertina RM. The influence of thrombin and platelets on fibrin clot lysis rates in vitro: A study using a clot lysis system consisting of purified human proteins. Fibrinolysis 02 1988; 235-244
    PubMedGoogle Scholar
  • 30 de Fouw NJ, Haverkate F, Bertina RM. Protein C and fibrinolysis: A link between coagulation and fibrinolysis. Adv Exp Med Biol 281 1990; 235-243
    PubMedGoogle Scholar
  • 31 Bajzar L, Fredenburgh JC, Nesheim ME. The activated protein C-mediated enhancement of tissue-type plasminogen activatorinduced fibrinolysis in a cell-free system. J Biol Chem 1990; 265: 16948-16954
    PubMedGoogle Scholar
  • 32 Bajzar L, Nesheim M. The effect of activated protein C on fibrinolysis in cell-free plasma can be attributed specifically to attenuation of prothrombin activation. J Biol Chem 1993; 268: 8608-8616
    PubMedGoogle Scholar
  • 33 Wang W, Hendriks DF, Scharpe SS. Carboxypeptidase U, a plasma carboxypeptidase with high affinity for plasminogen. J Biol Chem 269 1994; 15937-15944
    PubMedGoogle Scholar
  • 34 Bajzar L, Nesheim M, Tracy PB. Both cellular and soluble forms of thrombomodulin inhibit fibrinolysis by potentiating the activation of TAFI. Blood. submitted for publication
    PubMedGoogle Scholar
  • 35 Cote HCF, Stevens WK, Bajzar L, Banfield DK, Nesheim ME, MacGillivray RTA. Characterization of a stable form of human meizothrombin derived from recombinant prothrombin (R155A, R271A, and R284A). J Biol Chem 269 1994; 11374-11380
    PubMedGoogle Scholar
  • 36 Cote HCF, Bajzar L, Stevens WK, Samis J, Morser J, MacGillivray RTA, Nesheim ME. Functional characterization of recombinant human meizothrombin and meizothrombin(desFl). J Biol Chem. 1997. in press
    Google Scholar
  • 37 Wang W, Boffa MB, Walker J, Nesheim ME. A study of the mechanism of inhibition of tPA-mediated fibrinolysis by activated TAFI. Fibrinolysis 1996; 10 (278) 82 (abstract)
    PubMedGoogle Scholar
  • 38 Stearns DJ, Kurosawa S, Esmon CT. Microthrombomodulin. Residues 310-486 from the epidermal growth factor precursor homology domain of thrombomodulin will accelerate protein C activation. J Biol Chem 264 1989; 3352-3356
    PubMedGoogle Scholar
  • 39 Zushi M, Gomi K, Yamamoto S, Maruyama I, Hayashi T, Suzuki K. The last three consecutive epidermal growth factor-like structures of human thrombomodulin comprise the minimum functional domain for protein C-activating cofactor activity and anticoagulant activity. J Biol Chem 264 1989; 10351-10353
    CrossrefPubMedGoogle Scholar
  • 40 Hayashi T, Zushi M, Yamamoto S, Suzuki K. Further localization of binding sites for thrombin and protein C in human thrombomodulin. J Biol Chem 265 1990; 20156-20159
    PubMedGoogle Scholar
  • 41 Tsiang M, Lentz SR, Sadler JE. Functional domains of membrane-bound human thrombomodulin EGF-like domains four to six and the serine/threonine-rich domain are required for cofactor activity. J Biol Chem 267 1992; 6164-6170
    CrossrefPubMedGoogle Scholar
  • 42 Parkinson JF, Nagashima M, Kuhn I, Leonard J, Morser J. Stnicture-function studies of the epidermal growth factor domains of human thrombomodulin. Biochem Biophys Res Commun 185 1992; 567-576
    CrossrefPubMedGoogle Scholar
  • 43 Nagashima M, Lundh E, Leonard JC, Morser J, Parkinson JF. Alanine-scanning mutagenesis of the epidermal growth factor-like domains of human thrombomodulin identifies critical residues for its cofactor activity. J Biol Chem 268 1993; 2888-2892
    PubMedGoogle Scholar
  • 44 Glaser CB, Morser J, Clarke JH, Blasko E, McLean K, Kuhn I, Chang RJ, Lin JH, Vilander L, Andrews WH, Light DR. Oxidation of a specific methionine in thrombomodulin by activated neutrophil products blocks cofactor activity. A potential rapid mechanism for modulation of coagulation. J Clin Invest 1992; 90: 2565-2573
    CrossrefPubMedGoogle Scholar
  • 45 Clarke JH, Light DR, Blasko E, Parkinson JF, Nagashima M, McLean K, Vilander L, Andrews WH, Morser J, Glaser CB. The short loop between epidermal growth factor-like domains 4 and 5 is critical for human thrombomodulin function. J Biol Chem 268 1993; 6309-6315
    PubMedGoogle Scholar
  • 46 Lee CD, Mann KG. Activation/anactivation of human factor V by plasmin. Blood 73 1989; 185-190
    PubMedGoogle Scholar
  • 47 Giles AR, Nesheim ME, Herring SW, Hoogendoom H, Stump DC, Heldebrant CM. The fibrinolytic potential of the normal primate following the generation of thrombin in vivo. Thromb Haemost 1990; 63 (03) 476-481
    Article in Thieme ConnectPubMedGoogle Scholar
  • 48 Broze Jr G, Higuchi DA. Coagulation-dependent inhibition of fibrinolysis: role of carboxypeptidase-U and the premature lysis of clots from hemophilic plasma. Blood 88 1996; 3815-3823
    CrossrefPubMedGoogle Scholar
  • 49 Redlitz A, Nicolini FA, Malycky JL, Topol EJ, Plow EF. Inducible carboxypeptidase activity. A role in clot lysis in vivo. Circulation 93 1996; 1328-1330
    CrossrefPubMedGoogle Scholar
  • 50 Skidgel RA. Basic carboxypeptidases: Regulators of peptide hormone activity. Trends Pharmacol Sci 09 1988; 299-304
    CrossrefPubMedGoogle Scholar